Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus: 在失衡的糖尿病大鼠中血脂可以影响达比加群酯的抗凝作用
摘要背景无论患者是否合并糖尿病(DM), 达比加群酯(Dabigatran etexilate, DE)
预防脑卒中的疗效都相似. 然而, 目前在糖尿病患者中还没有看到具有减少大出血的获益. 因此 …
预防脑卒中的疗效都相似. 然而, 目前在糖尿病患者中还没有看到具有减少大出血的获益. 因此 …
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus
A Scridon, M Perian, A MĂrginean… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Dabigatran etexilate (DE) has similar stroke prevention efficacy in patients with
and without diabetes mellitus (DM). However, the benefit of reducing major bleeding was not …
and without diabetes mellitus (DM). However, the benefit of reducing major bleeding was not …
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus.
A Scridon, M Perian, A MĂrginean, A Huţanu… - Journal of …, 2017 - europepmc.org
Background Dabigatran etexilate (DE) has similar stroke prevention efficacy in patients with
and without diabetes mellitus (DM). However, the benefit of reducing major bleeding was not …
and without diabetes mellitus (DM). However, the benefit of reducing major bleeding was not …